⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for germline

Every month we try and update this database with for germline cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02975934
Metastatic Cast...
Rucaparib
Abiraterone ace...
18 Years - pharmaand GmbH
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic CancerNCT02790944
Pancreatic Duct...
Multi-gene Next...
18 Years - 89 YearsAmbry Genetics
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02975934
Metastatic Cast...
Rucaparib
Abiraterone ace...
18 Years - pharmaand GmbH
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesNCT04171700
Solid Tumor
Rucaparib
18 Years - pharmaand GmbH
Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant DeficiencyNCT04892693
Advanced Breast...
Talazoparib Ora...
19 Years - Seoul National University Hospital
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic CancerNCT02790944
Pancreatic Duct...
Multi-gene Next...
18 Years - 89 YearsAmbry Genetics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: